Logo image of BAM.CA

BROOKFIELD ASSET MGMT-A (BAM.CA) Stock Fundamental Analysis

TSX:BAM - Toronto Stock Exchange - CA1130041058 - Common Stock - Currency: CAD

83.4  -1.12 (-1.33%)

Fundamental Rating

5

Taking everything into account, BAM scores 5 out of 10 in our fundamental rating. BAM was compared to 79 industry peers in the Capital Markets industry. BAM has only an average score on both its financial health and profitability. While showing a medium growth rate, BAM is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year BAM was profitable.
In the past year BAM had a positive cash flow from operations.
In the past 5 years BAM has always been profitable.
BAM had a positive operating cash flow in 4 of the past 5 years.
BAM.CA Yearly Net Income VS EBIT VS OCF VS FCFBAM.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

1.2 Ratios

BAM's Return On Assets of 6.32% is fine compared to the rest of the industry. BAM outperforms 76.83% of its industry peers.
BAM has a Return On Equity of 9.08%. This is in the better half of the industry: BAM outperforms 71.95% of its industry peers.
The Return On Invested Capital of BAM (4.07%) is better than 70.73% of its industry peers.
BAM had an Average Return On Invested Capital over the past 3 years of 1.27%. This is significantly below the industry average of 7.96%.
The 3 year average ROIC (1.27%) for BAM is below the current ROIC(4.07%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.32%
ROE 9.08%
ROIC 4.07%
ROA(3y)9%
ROA(5y)7.21%
ROE(3y)13.06%
ROE(5y)12.5%
ROIC(3y)1.27%
ROIC(5y)3.38%
BAM.CA Yearly ROA, ROE, ROICBAM.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

BAM has a better Profit Margin (66.67%) than 84.15% of its industry peers.
BAM's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 51.23%, BAM belongs to the best of the industry, outperforming 80.49% of the companies in the same industry.
BAM's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 51.23%
PM (TTM) 66.67%
GM N/A
OM growth 3Y-30.79%
OM growth 5Y-18.69%
PM growth 3Y22.85%
PM growth 5Y4.98%
GM growth 3YN/A
GM growth 5YN/A
BAM.CA Yearly Profit, Operating, Gross MarginsBAM.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 20 40 60 80 100

6

2. Health

2.1 Basic Checks

The number of shares outstanding for BAM has been increased compared to 1 year ago.
Compared to 1 year ago, BAM has an improved debt to assets ratio.
BAM.CA Yearly Shares OutstandingBAM.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 100M 200M 300M 400M
BAM.CA Yearly Total Debt VS Total AssetsBAM.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

An Altman-Z score of 13.42 indicates that BAM is not in any danger for bankruptcy at the moment.
The Altman-Z score of BAM (13.42) is better than 87.80% of its industry peers.
BAM has a debt to FCF ratio of 2.09. This is a good value and a sign of high solvency as BAM would need 2.09 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 2.09, BAM is doing good in the industry, outperforming 75.61% of the companies in the same industry.
A Debt/Equity ratio of 0.15 indicates that BAM is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.15, BAM is doing good in the industry, outperforming 63.41% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 2.09
Altman-Z 13.42
ROIC/WACCN/A
WACCN/A
BAM.CA Yearly LT Debt VS Equity VS FCFBAM.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

BAM has a Current Ratio of 1.37. This is a normal value and indicates that BAM is financially healthy and should not expect problems in meeting its short term obligations.
BAM's Current ratio of 1.37 is fine compared to the rest of the industry. BAM outperforms 63.41% of its industry peers.
BAM has a Quick Ratio of 1.37. This is a normal value and indicates that BAM is financially healthy and should not expect problems in meeting its short term obligations.
BAM has a better Quick ratio (1.37) than 63.41% of its industry peers.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 1.37
BAM.CA Yearly Current Assets VS Current LiabilitesBAM.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2B 4B 6B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 11.76% over the past year.
The earnings per share for BAM have been decreasing by -22.95% on average. This is quite bad
The Revenue has grown by 264.78% in the past year. This is a very strong growth!
BAM shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -26.01% yearly.
EPS 1Y (TTM)11.76%
EPS 3Y-34.73%
EPS 5Y-22.95%
EPS Q2Q%21.21%
Revenue 1Y (TTM)264.78%
Revenue growth 3Y-46.15%
Revenue growth 5Y-26.01%
Sales Q2Q%-2.88%

3.2 Future

Based on estimates for the next years, BAM will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.74% on average per year.
Based on estimates for the next years, BAM will show a quite strong growth in Revenue. The Revenue will grow by 10.72% on average per year.
EPS Next Y13.8%
EPS Next 2Y15.04%
EPS Next 3Y15.74%
EPS Next 5YN/A
Revenue Next Year11.62%
Revenue Next 2Y12.62%
Revenue Next 3Y10.72%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BAM.CA Yearly Revenue VS EstimatesBAM.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
BAM.CA Yearly EPS VS EstimatesBAM.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 39.90 indicates a quite expensive valuation of BAM.
BAM's Price/Earnings ratio is a bit more expensive when compared to the industry. BAM is more expensive than 69.51% of the companies in the same industry.
BAM is valuated rather expensively when we compare the Price/Earnings ratio to 27.54, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 31.68 indicates a quite expensive valuation of BAM.
The rest of the industry has a similar Price/Forward Earnings ratio as BAM.
When comparing the Price/Forward Earnings ratio of BAM to the average of the S&P500 Index (36.44), we can say BAM is valued inline with the index average.
Industry RankSector Rank
PE 39.9
Fwd PE 31.68
BAM.CA Price Earnings VS Forward Price EarningsBAM.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

BAM's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 133.79
EV/EBITDA N/A
BAM.CA Per share dataBAM.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BAM does not grow enough to justify the current Price/Earnings ratio.
BAM has a very decent profitability rating, which may justify a higher PE ratio.
BAM's earnings are expected to grow with 15.74% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.89
PEG (5Y)N/A
EPS Next 2Y15.04%
EPS Next 3Y15.74%

3

5. Dividend

5.1 Amount

BAM has a Yearly Dividend Yield of 2.07%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 4.87, BAM has a dividend in line with its industry peers.
BAM's Dividend Yield is comparable with the S&P500 average which is at 2.35.
Industry RankSector Rank
Dividend Yield 2.07%

5.2 History

BAM has been paying a dividend for over 5 years, so it has already some track record.
BAM has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years3
Div Non Decr Years3
BAM.CA Yearly Dividends per shareBAM.CA Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

125.58% of the earnings are spent on dividend by BAM. This is not a sustainable payout ratio.
DP125.58%
EPS Next 2Y15.04%
EPS Next 3Y15.74%
BAM.CA Yearly Income VS Free CF VS DividendBAM.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B
BAM.CA Dividend Payout.BAM.CA Dividend Payout, showing the Payout Ratio.BAM.CA Dividend Payout.PayoutRetained Earnings

BROOKFIELD ASSET MGMT-A

TSX:BAM (7/18/2025, 7:00:00 PM)

83.4

-1.12 (-1.33%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)05-06 2025-05-06/bmo
Earnings (Next)08-06 2025-08-06/bmo
Inst Owners17%
Inst Owner ChangeN/A
Ins Owners1.94%
Ins Owner ChangeN/A
Market Cap136.57B
Analysts68.57
Price Target81.23 (-2.6%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.07%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP125.58%
Div Incr Years3
Div Non Decr Years3
Ex-Date05-30 2025-05-30 (0.4375)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.17%
Min EPS beat(2)-1.13%
Max EPS beat(2)1.46%
EPS beat(4)2
Avg EPS beat(4)0.88%
Min EPS beat(4)-2.55%
Max EPS beat(4)5.74%
EPS beat(8)4
Avg EPS beat(8)1.73%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-17.41%
Min Revenue beat(2)-17.67%
Max Revenue beat(2)-17.15%
Revenue beat(4)0
Avg Revenue beat(4)-9.23%
Min Revenue beat(4)-17.67%
Max Revenue beat(4)-0.58%
Revenue beat(8)0
Avg Revenue beat(8)-8.6%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.9%
PT rev (3m)-6.1%
EPS NQ rev (1m)-2.32%
EPS NQ rev (3m)-3.42%
EPS NY rev (1m)-0.69%
EPS NY rev (3m)-1.66%
Revenue NQ rev (1m)-0.92%
Revenue NQ rev (3m)-2.64%
Revenue NY rev (1m)0.23%
Revenue NY rev (3m)-0.78%
Valuation
Industry RankSector Rank
PE 39.9
Fwd PE 31.68
P/S 70.15
P/FCF 133.79
P/OCF 133.25
P/B 9.55
P/tB 9.55
EV/EBITDA N/A
EPS(TTM)2.09
EY2.51%
EPS(NY)2.63
Fwd EY3.16%
FCF(TTM)0.62
FCFY0.75%
OCF(TTM)0.63
OCFY0.75%
SpS1.19
BVpS8.73
TBVpS8.73
PEG (NY)2.89
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.32%
ROE 9.08%
ROCE 6.09%
ROIC 4.07%
ROICexc 4.18%
ROICexgc 4.38%
OM 51.23%
PM (TTM) 66.67%
GM N/A
FCFM 52.43%
ROA(3y)9%
ROA(5y)7.21%
ROE(3y)13.06%
ROE(5y)12.5%
ROIC(3y)1.27%
ROIC(5y)3.38%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)1.93%
ROCE(5y)4.85%
ROICexcg growth 3Y-36.28%
ROICexcg growth 5YN/A
ROICexc growth 3Y-36.35%
ROICexc growth 5YN/A
OM growth 3Y-30.79%
OM growth 5Y-18.69%
PM growth 3Y22.85%
PM growth 5Y4.98%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 2.09
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 31.61
Cash Conversion N/A
Profit Quality 78.65%
Current Ratio 1.37
Quick Ratio 1.37
Altman-Z 13.42
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)18.12%
Cap/Sales(5y)11.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.76%
EPS 3Y-34.73%
EPS 5Y-22.95%
EPS Q2Q%21.21%
EPS Next Y13.8%
EPS Next 2Y15.04%
EPS Next 3Y15.74%
EPS Next 5YN/A
Revenue 1Y (TTM)264.78%
Revenue growth 3Y-46.15%
Revenue growth 5Y-26.01%
Sales Q2Q%-2.88%
Revenue Next Year11.62%
Revenue Next 2Y12.62%
Revenue Next 3Y10.72%
Revenue Next 5YN/A
EBIT growth 1Y1072.58%
EBIT growth 3Y-62.73%
EBIT growth 5Y-39.83%
EBIT Next Year17.11%
EBIT Next 3Y17.48%
EBIT Next 5YN/A
FCF growth 1Y514.88%
FCF growth 3Y-25.34%
FCF growth 5Y-6.68%
OCF growth 1Y372.79%
OCF growth 3Y-24.26%
OCF growth 5Y-5.43%